AN ACT REQUIRING MANUFACTURERS OF BRAND-NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.
To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.
Introduced by:Sen. Martin M. Looney, 11th Dist.
|New today||2-4 days old||5 days & older|
Add Notes to SB-641
Go To My Bills
Co-sponsors for Amendment LCO:
|1/28/2021||Referred to Joint Committee on General Law|